News
![Why you can make Vertex Pharmaceuticals a buy on any pullback: https://www.marketbeat.com/logos/articles/med_20231108101211_why-you-can-make-vertex-a-buy-on-any-pullback.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBdzNPYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--cae87a8fc2648781a3d08aa5a867ec77b03270cc/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231108101211_why-you-can-make-vertex-a-buy-on-any-pullback.jpg?locale=us)
Why you can make Vertex Pharmaceuticals a buy on any pullback
Shares of Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) are down nearly 2% after the company delivered its third-quarter earnings report. The news wasn't particularly bad, although there was a
![Pfizer and Sanofi shares fall, which one to scoop up?: https://www.marketbeat.com/logos/articles/med_20231105150501_chart-pfe3.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBenpMYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--19d460008053b167cf51e29b4430fd46f4ef24a9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231105150501_chart-pfe3.jpg?locale=us)
Pfizer and Sanofi shares fall, which one to scoop up?
Pharmaceutical stocks aren't having quite the banner year they've had in the past. Notably, two large pharmaceutical companies recently plunged to 52-week lows on their earnings results. Many
![Pfizer and Sanofi shares fall, which one to scoop up?: https://www.marketbeat.com/logos/articles/med_20231105150501_chart-pfe3.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBenpMYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--19d460008053b167cf51e29b4430fd46f4ef24a9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231105150501_chart-pfe3.jpg?locale=us)
Pfizer and Sanofi shares fall, which one to scoop up?
Pharmaceutical stocks aren't having quite the banner year they've had in the past. Notably, two large pharmaceutical companies recently plunged to 52-week lows on their earnings results. Many
![Guidance leads the market for these stocks; 1 raises, 1 lowers: https://www.marketbeat.com/logos/articles/med_20231106115927_chart-abbv-1162023ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBem5MYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ca00c01365083cf758de1cbddc6c791afe797131/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231106115927_chart-abbv-1162023ver001.png?locale=us)
Guidance leads the market for these stocks; 1 raises, 1 lowers
Because earnings guidance is a company's best effort to forecast its earnings, it is a leading cause of share price movement. However, simply raising or lowering guidance is not enough to move a
![J&J stock down as business unit mulls talc-related bankruptcy: https://www.marketbeat.com/logos/articles/med_20231031061438_jj-stock-down-as-business-unit-mulls-talc-related.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNm5DYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3b4e4009717b3b79d8a100afaaf4d0d826bac35f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231031061438_jj-stock-down-as-business-unit-mulls-talc-related.jpg?locale=us)
J&J stock down as business unit mulls talc-related bankruptcy
Shares of Johnson & Johnson (NYSE: JNJ) slid 4.84% lower the week ending October 27, as the company’s subsidiary LTL Management is facing a raft of lawsuits pertaining to talc in its baby powder.
![J&J stock down as business unit mulls talc-related bankruptcy: https://www.marketbeat.com/logos/articles/med_20231031061438_jj-stock-down-as-business-unit-mulls-talc-related.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNm5DYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3b4e4009717b3b79d8a100afaaf4d0d826bac35f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231031061438_jj-stock-down-as-business-unit-mulls-talc-related.jpg?locale=us)
J&J stock down as business unit mulls talc-related bankruptcy
Shares of Johnson & Johnson (NYSE: JNJ) slid 4.84% lower the week ending October 27, as the company’s subsidiary LTL Management is facing a raft of lawsuits pertaining to talc in its baby powder.
![High-yield, deep-value AbbVie fell off the patent cliff and lived: https://www.marketbeat.com/logos/articles/med_20231027084929_high-yield-deep-value-abbvie-fell-off-the-patent-c.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM20vYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b84a2b98c39ccf1f28473ac7ff22aea7f1088448/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231027084929_high-yield-deep-value-abbvie-fell-off-the-patent-c.jpg?locale=us)
High-yield, deep-value AbbVie fell off the patent cliff and lived
Shares of AbbVie Inc. (NYSE: ABBV) have been under pressure for nearly two years because of mounting fears about the patent cliff. The patent cliff impacted the company’s results but has done
![The Value Deepens for Medtech Stocks: Reversal Imminent: https://www.marketbeat.com/logos/articles/med_20231023085140_chart-bax-10232023ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeFM1YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d1bd08a09883dcaf0726883a8123849ccee19e62/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231023085140_chart-bax-10232023ver001.png?locale=us)
The Value Deepens for Medtech Stocks: Reversal Imminent
Results from Johnson & Johnson (NYSE: JNJ) and Abbott Laboratories (NYSE: ABT) foreshadow good news for MedTech investors. Both companies outperformed on the top and bottom lines, driven by broad
![Oversold and Overextended, Abbott Laboratories is a Great Buy: https://www.marketbeat.com/logos/articles/med_20231018080123_chart-abt-10182023ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMmkwYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--4953dbca1ea9cdfdd288777a28824f138700e5aa/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231018080123_chart-abt-10182023ver001.png?locale=us)
Oversold and Overextended, Abbott Laboratories is a Great Buy
Abbott Laboratories (NYSE: ABT) share price has trended lower for nearly 2 years, but that trend is over. The impact of COVID on sales and the post-COVID letdown were cause enough for the market
![Walgreens Boots Alliance: Value or Value Trap?: https://www.marketbeat.com/logos/articles/med_20231012112832_chart-wba-10122023ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL091YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1220828144310370c5f4fd7115ffffe05f2e8bc9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231012112832_chart-wba-10122023ver001.png?locale=us)
Walgreens Boots Alliance: Value or Value Trap?
Walgreens Boots Alliance (NASDAQ: WBA) shares are down significantly over the past two years and may fall further. The company's turnaround efforts are slowly taking hold, and the impact of
![Prescriptions for Portfolio Health: 3 Resilient Healthcare Stocks: https://www.marketbeat.com/logos/articles/med_20231012063005_prescriptions-for-portfolio-health-3-resilient-hea.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBODJ0YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c5944d0ceb3b1a4bbf66b78e943d0a54c27f63ca/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231012063005_prescriptions-for-portfolio-health-3-resilient-hea.jpg?locale=us)
Prescriptions for Portfolio Health: 3 Resilient Healthcare Stocks
Over the last several months, many sectors, industries, and the overall market have come under pressure and experienced significant outflows and waves of selling.
During this period, over the
![Prescriptions for Portfolio Health: 3 Resilient Healthcare Stocks: https://www.marketbeat.com/logos/articles/med_20231012063005_prescriptions-for-portfolio-health-3-resilient-hea.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBODJ0YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c5944d0ceb3b1a4bbf66b78e943d0a54c27f63ca/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231012063005_prescriptions-for-portfolio-health-3-resilient-hea.jpg?locale=us)
Prescriptions for Portfolio Health: 3 Resilient Healthcare Stocks
Over the last several months, many sectors, industries, and the overall market have come under pressure and experienced significant outflows and waves of selling.
During this period, over the
![Prescriptions for Portfolio Health: 3 Resilient Healthcare Stocks: https://www.marketbeat.com/logos/articles/med_20231012063005_prescriptions-for-portfolio-health-3-resilient-hea.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBODJ0YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c5944d0ceb3b1a4bbf66b78e943d0a54c27f63ca/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231012063005_prescriptions-for-portfolio-health-3-resilient-hea.jpg?locale=us)
Prescriptions for Portfolio Health: 3 Resilient Healthcare Stocks
Over the last several months, many sectors, industries, and the overall market have come under pressure and experienced significant outflows and waves of selling.
During this period, over the
![Healthcare Giant Outperforms: A Healthy Dose of Market Resilience: https://www.marketbeat.com/logos/articles/med_20231009082049_healthcare-giant-outperforms-a-healthy-dose-of-mar.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNlNwYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1db26caf824eaff1d051d8ccef9cd9b6189ce20e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231009082049_healthcare-giant-outperforms-a-healthy-dose-of-mar.jpg?locale=us)
Healthcare Giant Outperforms: A Healthy Dose of Market Resilience
Over the last month, the overall market has experienced significant selling amid increased uncertainty. The S&P 500 ETF Trust (NYSE: SPY) has traded almost 5.5% lower in that period, and wherever
![Healthcare Giant Outperforms: A Healthy Dose of Market Resilience: https://www.marketbeat.com/logos/articles/med_20231009082049_healthcare-giant-outperforms-a-healthy-dose-of-mar.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNlNwYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1db26caf824eaff1d051d8ccef9cd9b6189ce20e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231009082049_healthcare-giant-outperforms-a-healthy-dose-of-mar.jpg?locale=us)
Healthcare Giant Outperforms: A Healthy Dose of Market Resilience
Over the last month, the overall market has experienced significant selling amid increased uncertainty. The S&P 500 ETF Trust (NYSE: SPY) has traded almost 5.5% lower in that period, and wherever
![3 Undervalued Healthcare Stocks to Watch as Sector Struggles: https://www.marketbeat.com/logos/articles/med_20231006072717_3-undervalued-healthcare-stocks-to-watch-as-sector.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeHVvYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--f900c3e8f374021907c2083400d74525a5cdca9c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231006072717_3-undervalued-healthcare-stocks-to-watch-as-sector.jpg?locale=us)
3 Undervalued Healthcare Stocks to Watch as Sector Struggles
The Health Care Select Sector SPDR Fund (NYSEARCA: XLV) is down 2.40% in the past three months, and down 4.67% year-to-date.
With the current sector-wide downturn, it’s not surprising that
![3 Undervalued Healthcare Stocks to Watch as Sector Struggles: https://www.marketbeat.com/logos/articles/med_20231006072717_3-undervalued-healthcare-stocks-to-watch-as-sector.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeHVvYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--f900c3e8f374021907c2083400d74525a5cdca9c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231006072717_3-undervalued-healthcare-stocks-to-watch-as-sector.jpg?locale=us)
3 Undervalued Healthcare Stocks to Watch as Sector Struggles
The Health Care Select Sector SPDR Fund (NYSEARCA: XLV) is down 2.40% in the past three months, and down 4.67% year-to-date.
With the current sector-wide downturn, it’s not surprising that
![3 Undervalued Healthcare Stocks to Watch as Sector Struggles: https://www.marketbeat.com/logos/articles/med_20231006072717_3-undervalued-healthcare-stocks-to-watch-as-sector.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeHVvYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--f900c3e8f374021907c2083400d74525a5cdca9c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231006072717_3-undervalued-healthcare-stocks-to-watch-as-sector.jpg?locale=us)
3 Undervalued Healthcare Stocks to Watch as Sector Struggles
The Health Care Select Sector SPDR Fund (NYSEARCA: XLV) is down 2.40% in the past three months, and down 4.67% year-to-date.
With the current sector-wide downturn, it’s not surprising that
![Are the S&P 500's Biggest Q3 Losers Next Year's Winners?: https://www.marketbeat.com/logos/articles/med_20231004081025_are-the-sp-500s-biggest-q3-losers-next-years-winne.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNENsYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--09da62c089805e53fd4ea879fb830168f9fa7d81/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231004081025_are-the-sp-500s-biggest-q3-losers-next-years-winne.jpg?locale=us)
Are the S&P 500's Biggest Q3 Losers Next Year's Winners?
What started out to be a promising third quarter for U.S. stocks turned into a dud. On the backs of artificial intelligence (AI) excitement, the S&P 500 stormed out of the gates in July only to
![Can Undervalued Healthcare Stocks Add Yield To Your Portfolio?: https://www.marketbeat.com/logos/articles/med_20230928074106_can-undervalued-healthcare-stocks-add-yield-to-you.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBLzZlYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--2d4bfb628f94a8120ac95affc214c0ccd49eb6c8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230928074106_can-undervalued-healthcare-stocks-add-yield-to-you.jpg?locale=us)
Can Undervalued Healthcare Stocks Add Yield To Your Portfolio?
If you had to guess the largest S&P company outside of big tech stocks or Berkshire Hathaway Inc. (NYSE: BRK.B), would you guess a healthcare stock?
Health insurer UnitedHealth Group Inc. (NYSE:
![2 Stocks to Benefit from the Aging Population: https://www.marketbeat.com/logos/articles/med_20230924134458_chart-abt2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOWFiYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--63ce225a495fe67b2a99fd35bc4529febeef2582/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230924134458_chart-abt2.jpg?locale=us)
2 Stocks to Benefit from the Aging Population
While the direction of the stock markets is unpredictable, the growth of the aging population is entirely predictable. Along with an aging population come additional healthcare, beauty and
![Are Gene Therapy Stocks The Market's Next Big Winners?: https://www.marketbeat.com/logos/articles/med_20230925062932_are-gene-therapy-stocks-the-markets-next-big-winne.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeUdiYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--32c516995736b99a5271f36da910e4b57cb21478/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230925062932_are-gene-therapy-stocks-the-markets-next-big-winne.jpg?locale=us)
Are Gene Therapy Stocks The Market's Next Big Winners?
It’s not often that you see a company whose main product comes with a price tag of over $2 million, but that’s the case with biotechs BioMarin Pharmaceutical (NASDAQ: BMRN) and Sarepta
![Argenx's 28% Surge & Promising Product Propel Investor Confidence: https://www.marketbeat.com/logos/articles/med_20230924200315_argenxs-28-surge-promising-product-propel-investor.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL21hYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--31f8233da06ba46411c0d97269db60cda1f70e3f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230924200315_argenxs-28-surge-promising-product-propel-investor.jpg?locale=us)
Argenx's 28% Surge & Promising Product Propel Investor Confidence
If you want to get an isolated view of a constructive base taking shape in a strong stock, take a look at the Argenix SE (NASDAQ: ARGX) chart.
The stock gapped up nearly 28% on July 17, after
![Flee to Healthcare Stocks if Recession Rears its Head?: https://www.marketbeat.com/logos/articles/med_20230919053331_flee-to-healthcare-stocks-if-recession-rears-its-h.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOCtXYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--995bc34015550a0096b18438d978b2e9bd10ebaa/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230919053331_flee-to-healthcare-stocks-if-recession-rears-its-h.jpg?locale=us)
Flee to Healthcare Stocks if Recession Rears its Head?
If you’re looking for a sector that’s on sale, look to healthcare. The Health Care Select Sector SPDR Fund (NYSEARCA: XLV) is down 2.50% in the past month, lagging the S&P 500.
The top
![Flee to Healthcare Stocks if Recession Rears its Head?: https://www.marketbeat.com/logos/articles/med_20230919053331_flee-to-healthcare-stocks-if-recession-rears-its-h.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOCtXYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--995bc34015550a0096b18438d978b2e9bd10ebaa/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230919053331_flee-to-healthcare-stocks-if-recession-rears-its-h.jpg?locale=us)
Flee to Healthcare Stocks if Recession Rears its Head?
If you’re looking for a sector that’s on sale, look to healthcare. The Health Care Select Sector SPDR Fund (NYSEARCA: XLV) is down 2.50% in the past month, lagging the S&P 500.
The top